{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:29:26Z","timestamp":1789694966266,"version":"4.0.1"},"reference-count":212,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270654,8256020605"],"award-info":[{"award-number":["82270654,8256020605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004772","name":"Ningxia Natural Science Foundation","doi-asserted-by":"crossref","award":["2021AAC03134, 2024AAC02041"],"award-info":[{"award-number":["2021AAC03134, 2024AAC02041"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia Hui Autonomous Region","doi-asserted-by":"crossref","award":["2023BEG02004, 2024BEG01001"],"award-info":[{"award-number":["2023BEG02004, 2024BEG01001"]}],"id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ningxia Science and Technology Leading Talent Training Project","award":["2023GKLRLX15"],"award-info":[{"award-number":["2023GKLRLX15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02997-8","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:14:49Z","timestamp":1781237689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Liver sinusoidal endothelial cell fenestrations in metabolic liver disease: from molecular mechanisms to therapeutic perspectives"],"prefix":"10.1186","volume":"24","author":[{"given":"Akram S.","family":"Al-Mughalles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangjin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-sen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"2997_CR1","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s11739-025-03895-6","volume":"20","author":"M Huang","year":"2025","unstructured":"Huang M, et al. Global burden and risk factors of MASLD: trends from 1990 to 2021 and predictions to 2030. Intern Emerg Med. 2025;20:1013\u201324. https:\/\/doi.org\/10.1007\/s11739-025-03895-6.","journal-title":"Intern Emerg Med"},{"key":"2997_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024;35:697\u2013707. https:\/\/doi.org\/10.1016\/j.tem.2024.02.007.","journal-title":"Trends Endocrinol Metab"},{"key":"2997_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11427-024-2722-2","volume":"68","author":"J Xiao","year":"2025","unstructured":"Xiao J, et al. Epidemiology of liver diseases: global disease burden and forecasted research trends. Sci China Life Sci. 2025;68:541\u201357. https:\/\/doi.org\/10.1007\/s11427-024-2722-2.","journal-title":"Sci China Life Sci"},{"key":"2997_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s00018-023-04966-7","volume":"80","author":"RI Velliou","year":"2023","unstructured":"Velliou RI, Legaki AI, Nikolakopoulou P, Vlachogiannis NI, Chatzigeorgiou A. Liver endothelial cells in NAFLD and transition to NASH and HCC. Cell Mol Life Sci. 2023;80:314. https:\/\/doi.org\/10.1007\/s00018-023-04966-7.","journal-title":"Cell Mol Life Sci"},{"key":"2997_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/biomedicines13040855","volume":"13","author":"I Milani","year":"2025","unstructured":"Milani I, Chinucci M, Leonetti F, Capoccia D. MASLD: prevalence, mechanisms, and sex-based therapies in postmenopausal women. Biomedicines. 2025;13:855. https:\/\/doi.org\/10.3390\/biomedicines13040855.","journal-title":"Biomedicines"},{"key":"2997_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12964-024-01720-9","volume":"22","author":"Q He","year":"2024","unstructured":"He Q, et al. Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease. Cell Commun Signal. 2024;22:346. https:\/\/doi.org\/10.1186\/s12964-024-01720-9.","journal-title":"Cell Commun Signal"},{"key":"2997_CR7","doi-asserted-by":"publisher","first-page":"G246","DOI":"10.1152\/ajpgi.00118.2016","volume":"311","author":"E Kostallari","year":"2016","unstructured":"Kostallari E, Shah VH. Angiocrine signaling in the hepatic sinusoids in health and disease. Am J Physiol Gastrointest Liver Physiol. 2016;311:G246\u201351. https:\/\/doi.org\/10.1152\/ajpgi.00118.2016.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2997_CR8","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41423-025-01313-7","volume":"22","author":"E Kostallari","year":"2025","unstructured":"Kostallari E, Schwabe RF, Guillot A. Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells. Cell Mol Immunol. 2025;22:1205\u201325. https:\/\/doi.org\/10.1038\/s41423-025-01313-7.","journal-title":"Cell Mol Immunol"},{"key":"2997_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","volume":"15","author":"S Shetty","year":"2018","unstructured":"Shetty S, Lalor PF, Adams DH. Liver sinusoidal endothelial cells \u2013 gatekeepers of hepatic immunity. Nat Rev Gastroenterol Hepatol. 2018;15:555\u201367. https:\/\/doi.org\/10.1038\/s41575-018-0020-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2997_CR10","doi-asserted-by":"publisher","first-page":"103121","DOI":"10.1016\/j.micron.2021.103121","volume":"150","author":"K Szafranska","year":"2021","unstructured":"Szafranska K, et al. Quantitative analysis methods for studying fenestrations in liver sinusoidal endothelial cells. A comparative study. Micron. 2021;150:103121. https:\/\/doi.org\/10.1016\/j.micron.2021.103121.","journal-title":"Micron"},{"key":"2997_CR11","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.3390\/cells10102712","volume":"10","author":"JK Hennigs","year":"2021","unstructured":"Hennigs JK, Matuszcak C, Trepel M, Korbelin J. Vascular endothelial cells: heterogeneity and targeting approaches. Cells. 2021;10:2712. https:\/\/doi.org\/10.3390\/cells10102712.","journal-title":"Cells"},{"key":"2997_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s11658-024-00655-w","volume":"29","author":"I Czyzynska-Cichon","year":"2024","unstructured":"Czyzynska-Cichon I, et al. Early and late phases of liver sinusoidal endothelial cell (LSEC) defenestration in mouse model of systemic inflammation. Cell Mol Biol Lett. 2024;29:139. https:\/\/doi.org\/10.1186\/s11658-024-00655-w.","journal-title":"Cell Mol Biol Lett"},{"key":"2997_CR13","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/labinvest.2015.95","volume":"95","author":"M Miyao","year":"2015","unstructured":"Miyao M, et al. Pivotal role of liver sinusoidal endothelial cells in NAFLD\/NASH progression. Lab Invest. 2015;95:1130\u201344. https:\/\/doi.org\/10.1038\/labinvest.2015.95.","journal-title":"Lab Invest"},{"key":"2997_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","volume":"122","author":"V Lekakis","year":"2024","unstructured":"Lekakis V, Papatheodoridis GV. Natural history of metabolic dysfunction-associated steatotic liver disease. Eur J Intern Med. 2024;122:3\u201310. https:\/\/doi.org\/10.1016\/j.ejim.2023.11.005.","journal-title":"Eur J Intern Med"},{"key":"2997_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s44161-024-00490-4","volume":"3","author":"N Ciriaci","year":"2024","unstructured":"Ciriaci N, Rautou PE, Poisson J. Loss of fenestrae in liver sinusoidal endothelial cells contributes to MASLD. Nat Cardiovasc Res. 2024;3:622\u20134. https:\/\/doi.org\/10.1038\/s44161-024-00490-4.","journal-title":"Nat Cardiovasc Res"},{"key":"2997_CR16","doi-asserted-by":"publisher","first-page":"12003","DOI":"10.3892\/mmr.2021.12003","volume":"23","author":"QN Cheng","year":"2021","unstructured":"Cheng QN, Yang X, Wu JF, Ai WB, Ni YR. Interaction of non-parenchymal hepatocytes in the process of hepatic fibrosis (Review). Mol Med Rep. 2021;23:12003. https:\/\/doi.org\/10.3892\/mmr.2021.12003.","journal-title":"Mol Med Rep"},{"key":"2997_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jhep.2024.05.014","volume":"81","author":"J Gao","year":"2024","unstructured":"Gao J, et al. Angiocrine signaling in sinusoidal homeostasis and liver diseases. J Hepatol. 2024;81:543\u201361. https:\/\/doi.org\/10.1016\/j.jhep.2024.05.014.","journal-title":"J Hepatol"},{"key":"2997_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11010-020-03903-7","volume":"476","author":"WL Wang","year":"2021","unstructured":"Wang WL, et al. The effect of aging on VEGF\/VEGFR2 signal pathway genes expression in rat liver sinusoidal endothelial cell. Mol Cell Biochem. 2021;476:269\u201377. https:\/\/doi.org\/10.1007\/s11010-020-03903-7.","journal-title":"Mol Cell Biochem"},{"key":"2997_CR19","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1242\/dev.01902","volume":"132","author":"B Carpenter","year":"2005","unstructured":"Carpenter B, et al. VEGF is crucial for the hepatic vascular development required for lipoprotein uptake. Development. 2005;132:3293\u2013303. https:\/\/doi.org\/10.1242\/dev.01902.","journal-title":"Development"},{"key":"2997_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3389\/fphys.2020.00767","volume":"11","author":"RP Cunningham","year":"2020","unstructured":"Cunningham RP, Sheldon RD, Rector RS. The emerging role of hepatocellular eNOS in non-alcoholic fatty liver disease development. Front Physiol. 2020;11:767. https:\/\/doi.org\/10.3389\/fphys.2020.00767.","journal-title":"Front Physiol"},{"key":"2997_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12876-015-0409-9","volume":"15","author":"Y Nozaki","year":"2015","unstructured":"Nozaki Y, et al. Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution. BMC Gastroenterol. 2015;15:177. https:\/\/doi.org\/10.1186\/s12876-015-0409-9.","journal-title":"BMC Gastroenterol"},{"key":"2997_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-1-4939-8612-5_19","volume":"2018","author":"AJ Santiago-Lopez","year":"1821","unstructured":"Santiago-Lopez AJ, Gutekunst CA, Gross RE. Rho GTPases Methods Mol Biol. 1821;2018:267\u201381. https:\/\/doi.org\/10.1007\/978-1-4939-8612-5_19.","journal-title":"Rho GTPases Methods Mol Biol"},{"key":"2997_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4161\/cam.5.2.14403","volume":"5","author":"D Spiering","year":"2011","unstructured":"Spiering D, Hodgson L. Dynamics of the Rho-family small GTPases in actin regulation and motility. Cell Adh Migr. 2011;5:170\u201380. https:\/\/doi.org\/10.4161\/cam.5.2.14403.","journal-title":"Cell Adh Migr"},{"key":"2997_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/labinvest.3700114","volume":"84","author":"H Yokomori","year":"2004","unstructured":"Yokomori H, et al. Rho modulates hepatic sinusoidal endothelial fenestrae via regulation of the actin cytoskeleton in rat endothelial cells. Lab Invest. 2004;84:857\u201364. https:\/\/doi.org\/10.1038\/labinvest.3700114.","journal-title":"Lab Invest"},{"key":"2997_CR25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.yexcr.2005.05.001","volume":"308","author":"MC Gutjahr","year":"2005","unstructured":"Gutjahr MC, Rossy J, Niggli V. Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells. Exp Cell Res. 2005;308:422\u201338. https:\/\/doi.org\/10.1016\/j.yexcr.2005.05.001.","journal-title":"Exp Cell Res"},{"key":"2997_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0002-9440(10)63849-7","volume":"162","author":"H Yokomori","year":"2003","unstructured":"Yokomori H, et al. Endothelin-1 suppresses plasma membrane Ca++-ATPase, concomitant with contraction of hepatic sinusoidal endothelial fenestrae. Am J Pathol. 2003;162:557\u201366. https:\/\/doi.org\/10.1016\/S0002-9440(10)63849-7.","journal-title":"Am J Pathol"},{"key":"2997_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/SHK.0000000000000252","volume":"42","author":"W Kwok","year":"2014","unstructured":"Kwok W, Clemens MG. Rho-kinase activation contributes to LPS-induced impairment of endothelial nitric oxide synthase activation by endothelin-1 in cultured hepatic sinusoidal endothelial cells. Shock. 2014;42:554\u201361. https:\/\/doi.org\/10.1097\/SHK.0000000000000252.","journal-title":"Shock"},{"key":"2997_CR28","doi-asserted-by":"publisher","first-page":"e109017","DOI":"10.1371\/journal.pone.0109017","volume":"9","author":"T Maruhashi","year":"2014","unstructured":"Maruhashi T, et al. Critical role of exogenous nitric oxide in ROCK activity in vascular smooth muscle cells. PLoS One. 2014;9:e109017. https:\/\/doi.org\/10.1371\/journal.pone.0109017.","journal-title":"PLoS One"},{"key":"2997_CR29","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1167\/iovs.17-23580","volume":"59","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, et al. The role of the RhoA\/ROCK signaling pathway in mechanical strain-induced scleral myofibroblast differentiation. Invest Ophthalmol Vis Sci. 2018;59:3619\u201329. https:\/\/doi.org\/10.1167\/iovs.17-23580.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2997_CR30","doi-asserted-by":"publisher","unstructured":"Hu Y, et al. Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis. Cell. 2026;in press. https:\/\/doi.org\/10.1016\/j.cell.2026.02.001.","DOI":"10.1016\/j.cell.2026.02.001"},{"key":"2997_CR31","doi-asserted-by":"crossref","unstructured":"Cogger VC, Hunt NJ, Le Couteur DG. Hallmarks of aging in the liver. In: The liver. 2020. pp. 435-43.","DOI":"10.1002\/9781119436812.ch35"},{"key":"2997_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12944-025-02563-0","volume":"24","author":"M Warda","year":"2025","unstructured":"Warda M, et al. Lipid rafts: novel therapeutic targets for metabolic, neurodegenerative, oncological, and cardiovascular diseases. Lipids Health Dis. 2025;24:147. https:\/\/doi.org\/10.1186\/s12944-025-02563-0.","journal-title":"Lipids Health Dis"},{"key":"2997_CR33","doi-asserted-by":"publisher","first-page":"722394","DOI":"10.3389\/fphys.2021.722394","volume":"12","author":"PS Koch","year":"2021","unstructured":"Koch PS, et al. Imbalanced activation of Wnt\/\u03b2-catenin signaling in liver endothelium alters normal sinusoidal differentiation. Front Physiol. 2021;12:722394. https:\/\/doi.org\/10.3389\/fphys.2021.722394.","journal-title":"Front Physiol"},{"key":"2997_CR34","doi-asserted-by":"publisher","first-page":"101376","DOI":"10.1016\/j.redox.2019.101376","volume":"29","author":"M Lamas Bervejillo","year":"2020","unstructured":"Lamas Bervejillo M, et al. A FABP4-PPAR\u03b3 signaling axis regulates human monocyte responses to electrophilic fatty acid nitroalkenes. Redox Biol. 2020;29:101376. https:\/\/doi.org\/10.1016\/j.redox.2019.101376.","journal-title":"Redox Biol"},{"key":"2997_CR35","doi-asserted-by":"publisher","first-page":"G375","DOI":"10.1152\/ajpgi.00288.2011","volume":"302","author":"TC Hang","year":"2012","unstructured":"Hang TC, Lauffenburger DA, Griffith LG, Stolz DB. Lipids promote survival, proliferation, and maintenance of differentiation of rat liver sinusoidal endothelial cells in vitro. Am J Physiol Gastrointest Liver Physiol. 2012;302:G375\u201388. https:\/\/doi.org\/10.1152\/ajpgi.00288.2011.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2997_CR36","doi-asserted-by":"publisher","first-page":"166810","DOI":"10.1016\/j.bbadis.2023.166810","volume":"1869","author":"C Zhou","year":"2023","unstructured":"Zhou C, et al. FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression. Biochim Biophys Acta Mol Basis Dis. 2023;1869:166810. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166810.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2997_CR37","doi-asserted-by":"publisher","first-page":"e2003721","DOI":"10.1002\/advs.202003721","volume":"8","author":"X Wu","year":"2021","unstructured":"Wu X, et al. Adipocyte fatty acid binding protein promotes the onset and progression of liver fibrosis via mediating the crosstalk between liver sinusoidal endothelial cells and hepatic stellate cells. Adv Sci (Weinh). 2021;8:e2003721. https:\/\/doi.org\/10.1002\/advs.202003721.","journal-title":"Adv Sci (Weinh)"},{"key":"2997_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-024-01888-z","volume":"9","author":"J Su","year":"2024","unstructured":"Su J, et al. Cell-cell communication: new insights and clinical implications. Signal Transduct Target Ther. 2024;9:196. https:\/\/doi.org\/10.1038\/s41392-024-01888-z.","journal-title":"Signal Transduct Target Ther"},{"key":"2997_CR39","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jhep.2016.04.018","volume":"65","author":"G Marrone","year":"2016","unstructured":"Marrone G, Shah VH, Gracia-Sancho J. Sinusoidal communication in liver fibrosis and regeneration. J Hepatol. 2016;65:608\u201317. https:\/\/doi.org\/10.1016\/j.jhep.2016.04.018.","journal-title":"J Hepatol"},{"key":"2997_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/cmi.2016.5","volume":"13","author":"PA Knolle","year":"2016","unstructured":"Knolle PA, Wohlleber D. Immunological functions of liver sinusoidal endothelial cells. Cell Mol Immunol. 2016;13:347\u201353. https:\/\/doi.org\/10.1038\/cmi.2016.5.","journal-title":"Cell Mol Immunol"},{"key":"2997_CR41","doi-asserted-by":"publisher","first-page":"4097205","DOI":"10.1155\/2017\/4097205","volume":"2017","author":"V Natarajan","year":"2017","unstructured":"Natarajan V, Harris EN, Kidambi S. SECs (sinusoidal endothelial cells), liver microenvironment, and fibrosis. Biomed Res Int. 2017;2017:4097205. https:\/\/doi.org\/10.1155\/2017\/4097205.","journal-title":"Biomed Res Int"},{"key":"2997_CR42","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/hep.22351","volume":"48","author":"LD Deleve","year":"2008","unstructured":"Deleve LD, Wang X, Guo Y. Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology. 2008;48:920\u201330. https:\/\/doi.org\/10.1002\/hep.22351.","journal-title":"Hepatology"},{"key":"2997_CR43","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/hep4.1356","volume":"3","author":"A Guillot","year":"2019","unstructured":"Guillot A, Tacke F. Liver macrophages: old dogmas and new insights. Hepatol Commun. 2019;3:730\u201343. https:\/\/doi.org\/10.1002\/hep4.1356.","journal-title":"Hepatol Commun"},{"key":"2997_CR44","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/hep.21497","volume":"45","author":"PF Lalor","year":"2007","unstructured":"Lalor PF, et al. Activation of vascular adhesion protein-1 on liver endothelium results in an NF-\u03baB-dependent increase in lymphocyte adhesion. Hepatology. 2007;45:465\u201374. https:\/\/doi.org\/10.1002\/hep.21497.","journal-title":"Hepatology"},{"key":"2997_CR45","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.4049\/jimmunol.1002961","volume":"186","author":"S Shetty","year":"2011","unstructured":"Shetty S, et al. Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium. J Immunol. 2011;186:4147\u201355. https:\/\/doi.org\/10.4049\/jimmunol.1002961.","journal-title":"J Immunol"},{"key":"2997_CR46","doi-asserted-by":"publisher","first-page":"936196","DOI":"10.3389\/fimmu.2022.936196","volume":"13","author":"W Du","year":"2022","unstructured":"Du W, Wang L. The crosstalk between liver sinusoidal endothelial cells and hepatic microenvironment in NASH related liver fibrosis. Front Immunol. 2022;13:936196. https:\/\/doi.org\/10.3389\/fimmu.2022.936196.","journal-title":"Front Immunol"},{"key":"2997_CR47","doi-asserted-by":"publisher","first-page":"e22125","DOI":"10.1096\/fj.202101426R","volume":"36","author":"Y Wan","year":"2022","unstructured":"Wan Y, et al. Endothelial dysfunction in pathological processes of chronic liver disease during aging. FASEB J. 2022;36:e22125. https:\/\/doi.org\/10.1096\/fj.202101426R.","journal-title":"FASEB J"},{"key":"2997_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/a-2128-5907","volume":"43","author":"SA Cooper","year":"2023","unstructured":"Cooper SA, Kostallari E, Shah VH. Angiocrine signaling in sinusoidal health and disease. Semin Liver Dis. 2023;43:245\u201357. https:\/\/doi.org\/10.1055\/a-2128-5907.","journal-title":"Semin Liver Dis"},{"key":"2997_CR49","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jhep.2019.02.012","volume":"70","author":"A Hammoutene","year":"2019","unstructured":"Hammoutene A, Rautou PE. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. J Hepatol. 2019;70:1278\u201391. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.012.","journal-title":"J Hepatol"},{"key":"2997_CR50","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jhep.2019.10.028","volume":"72","author":"A Hammoutene","year":"2020","unstructured":"Hammoutene A, et al. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis. J Hepatol. 2020;72:528\u201338. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.028.","journal-title":"J Hepatol"},{"key":"2997_CR51","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1038\/s41467-024-48956-0","volume":"15","author":"L Verschuren","year":"2024","unstructured":"Verschuren L, et al. Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD. Nat Commun. 2024;15:4564. https:\/\/doi.org\/10.1038\/s41467-024-48956-0.","journal-title":"Nat Commun"},{"key":"2997_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10456-025-09969-5","volume":"28","author":"H Mo","year":"2025","unstructured":"Mo H, et al. The role of liver sinusoidal endothelial cells in metabolic dysfunction-associated steatotic liver diseases and liver cancer: mechanisms and potential therapies. Angiogenesis. 2025;28:14. https:\/\/doi.org\/10.1007\/s10456-025-09969-5.","journal-title":"Angiogenesis"},{"key":"2997_CR53","doi-asserted-by":"publisher","first-page":"151881","DOI":"10.1016\/j.bbrc.2025.151881","volume":"766","author":"T Chen","year":"2025","unstructured":"Chen T, Zhang H, Shan W, Zhou J, You Y. Liver sinusoidal endothelial cells in hepatic fibrosis: opportunities for future strategies. Biochem Biophys Res Commun. 2025;766:151881. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151881.","journal-title":"Biochem Biophys Res Commun"},{"key":"2997_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/biology9110395","volume":"9","author":"K Furuta","year":"2020","unstructured":"Furuta K, Guo Q, Hirsova P, Ibrahim SH. Emerging roles of liver sinusoidal endothelial cells in nonalcoholic steatohepatitis. Biology (Basel). 2020;9:395. https:\/\/doi.org\/10.3390\/biology9110395.","journal-title":"Biology (Basel)"},{"key":"2997_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s44355-024-00014-8","volume":"2","author":"H Leal-Lassalle","year":"2025","unstructured":"Leal-Lassalle H, Est\u00e9vez-V\u00e1zquez O, Cubero FJ, Nevzorova YA. Metabolic and alcohol-associated liver disease (MetALD): a representation of duality. NPJ Gut Liver. 2025;2:14. https:\/\/doi.org\/10.1038\/s44355-024-00014-8.","journal-title":"NPJ Gut Liver."},{"key":"2997_CR56","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jhep.2021.02.028","volume":"75","author":"Y Yang","year":"2021","unstructured":"Yang Y, et al. Alcohol-induced Hsp90 acetylation is a novel driver of liver sinusoidal endothelial dysfunction and alcohol-related liver disease. J Hepatol. 2021;75:377\u201386. https:\/\/doi.org\/10.1016\/j.jhep.2021.02.028.","journal-title":"J Hepatol"},{"key":"2997_CR57","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","volume":"10","author":"X Xu","year":"2025","unstructured":"Xu X, Pang Y, Fan X. Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Signal Transduct Target Ther. 2025;10:190. https:\/\/doi.org\/10.1038\/s41392-025-02253-4.","journal-title":"Signal Transduct Target Ther"},{"key":"2997_CR58","doi-asserted-by":"publisher","first-page":"17756","DOI":"10.3748\/wjg.v20.i47.17756","volume":"20","author":"E Ceni","year":"2014","unstructured":"Ceni E, Mello T, Galli A. Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World J Gastroenterol. 2014;20:17756\u201372. https:\/\/doi.org\/10.3748\/wjg.v20.i47.17756.","journal-title":"World J Gastroenterol"},{"key":"2997_CR59","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3390\/antiox14101196","volume":"14","author":"JY Lee","year":"2025","unstructured":"Lee JY, Jee YM, Yang K, Ryu T. Alcohol-induced oxidative stress and gut-liver-brain crosstalk: expanding the paradigm from ALD to MetALD. Antioxidants (Basel). 2025;14:1196. https:\/\/doi.org\/10.3390\/antiox14101196.","journal-title":"Antioxidants (Basel)"},{"key":"2997_CR60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jhep.2018.10.023","volume":"70","author":"B Gao","year":"2019","unstructured":"Gao B, Ahmad MF, Nagy LE, Tsukamoto H. Inflammatory pathways in alcoholic steatohepatitis. J Hepatol. 2019;70:249\u201359. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.023.","journal-title":"J Hepatol"},{"key":"2997_CR61","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41575-024-01014-y","volume":"22","author":"EE Powell","year":"2025","unstructured":"Powell EE. A new treatment and updated clinical practice guidelines for MASLD. Nat Rev Gastroenterol Hepatol. 2025;22:88\u20139. https:\/\/doi.org\/10.1038\/s41575-024-01014-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2997_CR62","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41392-022-01233-2","volume":"7","author":"J Chen","year":"2022","unstructured":"Chen J, Zhou R, Feng Y, Cheng L. Molecular mechanisms of exercise contributing to tissue regeneration. Signal Transduct Target Ther. 2022;7:383. https:\/\/doi.org\/10.1038\/s41392-022-01233-2.","journal-title":"Signal Transduct Target Ther"},{"key":"2997_CR63","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/jcm13051406","volume":"13","author":"I Minciuna","year":"2024","unstructured":"Minciuna I, Taru MG, Procopet B, Stefanescu H. The interplay between liver sinusoidal endothelial cells, platelets, and neutrophil extracellular traps in the development and progression of metabolic dysfunction-associated steatotic liver disease. J Clin Med. 2024;13:1406. https:\/\/doi.org\/10.3390\/jcm13051406.","journal-title":"J Clin Med"},{"key":"2997_CR64","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","volume":"66","author":"J Poisson","year":"2017","unstructured":"Poisson J, et al. Liver sinusoidal endothelial cells: physiology and role in liver diseases. J Hepatol. 2017;66:212\u201327. https:\/\/doi.org\/10.1016\/j.jhep.2016.07.009.","journal-title":"J Hepatol"},{"key":"2997_CR65","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126:1549\u201364. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315896.","journal-title":"Circ Res"},{"key":"2997_CR66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1101\/gad.346312.120","volume":"35","author":"YS Lee","year":"2021","unstructured":"Lee YS, Olefsky J. Chronic tissue inflammation and metabolic disease. Genes Dev. 2021;35:307\u201328. https:\/\/doi.org\/10.1101\/gad.346312.120.","journal-title":"Genes Dev"},{"key":"2997_CR67","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/HEP.0000000000000207","volume":"78","author":"MJ McConnell","year":"2023","unstructured":"McConnell MJ, Kostallari E, Ibrahim SH, Iwakiri Y. The evolving role of liver sinusoidal endothelial cells in liver health and disease. Hepatology. 2023;78:649\u201369. https:\/\/doi.org\/10.1097\/HEP.0000000000000207.","journal-title":"Hepatology"},{"key":"2997_CR68","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nyas.15184","volume":"1538","author":"W Fan","year":"2024","unstructured":"Fan W, Bradford TM, Torok NJ. Metabolic dysfunction-associated liver disease and diabetes: matrix remodeling, fibrosis, and therapeutic implications. Ann N Y Acad Sci. 2024;1538:21\u201333. https:\/\/doi.org\/10.1111\/nyas.15184.","journal-title":"Ann N Y Acad Sci"},{"key":"2997_CR69","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.cmet.2025.03.015","volume":"37","author":"B He","year":"2025","unstructured":"He B, et al. Spatial regulation of glucose and lipid metabolism by hepatic insulin signaling. Cell Metab. 2025;37:1568-83.e7. https:\/\/doi.org\/10.1016\/j.cmet.2025.03.015.","journal-title":"Cell Metab"},{"key":"2997_CR70","doi-asserted-by":"publisher","first-page":"e0161834","DOI":"10.1371\/journal.pone.0161834","volume":"11","author":"P Shah","year":"2016","unstructured":"Shah P, et al. Angiopoietin-2 signals do not mediate the hypervascularization of islets in type 2 diabetes. PLoS One. 2016;11:e0161834. https:\/\/doi.org\/10.1371\/journal.pone.0161834.","journal-title":"PLoS One"},{"key":"2997_CR71","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/jcm14020428","volume":"14","author":"E Michalopoulou","year":"2025","unstructured":"Michalopoulou E, et al. The triad of risk: linking MASLD, cardiovascular disease and type 2 diabetes; from pathophysiology to treatment. J Clin Med. 2025;14:428. https:\/\/doi.org\/10.3390\/jcm14020428.","journal-title":"J Clin Med"},{"key":"2997_CR72","doi-asserted-by":"publisher","first-page":"G518","DOI":"10.1152\/ajpgi.00024.2006","volume":"292","author":"P Brun","year":"2007","unstructured":"Brun P, et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2007;292:G518\u201325. https:\/\/doi.org\/10.1152\/ajpgi.00024.2006.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2997_CR73","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.repbio.2020.04.006","volume":"20","author":"M Oncul","year":"2020","unstructured":"Oncul M, et al. Polycystic ovary syndrome and endothelial dysfunction: a potential role for soluble lectin-like oxidized low density lipoprotein receptor-1. Reprod Biol. 2020;20:396\u2013401. https:\/\/doi.org\/10.1016\/j.repbio.2020.04.006.","journal-title":"Reprod Biol"},{"key":"2997_CR74","doi-asserted-by":"publisher","first-page":"12655","DOI":"10.3390\/ijms241612655","volume":"24","author":"Y Shi","year":"2023","unstructured":"Shi Y, et al. Pathophysiological insight into fatty acid-binding protein-4: multifaced roles in reproduction, pregnancy, and offspring health. Int J Mol Sci. 2023;24:12655. https:\/\/doi.org\/10.3390\/ijms241612655.","journal-title":"Int J Mol Sci"},{"key":"2997_CR75","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s12020-023-03516-2","volume":"83","author":"M Sun","year":"2024","unstructured":"Sun M, et al. Androgen-induced upregulation of CFTR in pancreatic \u03b2-cell contributes to hyperinsulinemia in PCOS model. Endocrine. 2024;83:242\u201350. https:\/\/doi.org\/10.1007\/s12020-023-03516-2.","journal-title":"Endocrine"},{"key":"2997_CR76","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41421-025-00769-1","volume":"11","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, et al. Transgenerational inheritance of diabetes susceptibility in male offspring with maternal androgen exposure. Cell Discov. 2025;11:14. https:\/\/doi.org\/10.1038\/s41421-025-00769-1.","journal-title":"Cell Discov"},{"key":"2997_CR77","doi-asserted-by":"publisher","first-page":"108827","DOI":"10.3748\/wjg.v31.i32.108827","volume":"31","author":"AM Vargas-Beltran","year":"2025","unstructured":"Vargas-Beltran AM, et al. Interplay between endocrine disorders and liver dysfunction: mechanisms of damage and therapeutic approaches. World J Gastroenterol. 2025;31:108827. https:\/\/doi.org\/10.3748\/wjg.v31.i32.108827.","journal-title":"World J Gastroenterol"},{"key":"2997_CR78","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.immuni.2023.05.001","volume":"56","author":"JH Li","year":"2023","unstructured":"Li JH, Hepworth MR, O\u2019Sullivan TE. Regulation of systemic metabolism by tissue-resident immune cell circuits. Immunity. 2023;56:1168\u201386. https:\/\/doi.org\/10.1016\/j.immuni.2023.05.001.","journal-title":"Immunity"},{"key":"2997_CR79","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","volume":"68","author":"F Marra","year":"2018","unstructured":"Marra F, Svegliati-Baroni G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol. 2018;68:280\u201395. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.014.","journal-title":"J Hepatol"},{"key":"2997_CR80","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1053\/jhep.2001.22754","volume":"33","author":"DG Le Couteur","year":"2001","unstructured":"Le Couteur DG, et al. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology. 2001;33:537\u201343. https:\/\/doi.org\/10.1053\/jhep.2001.22754.","journal-title":"Hepatology"},{"key":"2997_CR81","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/00313021003636469","volume":"42","author":"JN O'Reilly","year":"2010","unstructured":"O\u2019Reilly JN, Cogger VC, Fraser R, Le Couteur DG. The effect of feeding and fasting on fenestrations in the liver sinusoidal endothelial cell. Pathology. 2010;42:255\u20138. https:\/\/doi.org\/10.3109\/00313021003636469.","journal-title":"Pathology"},{"key":"2997_CR82","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.exger.2006.11.004","volume":"42","author":"HA Jamieson","year":"2007","unstructured":"Jamieson HA, et al. Caloric restriction reduces age-related pseudocapillarization of the hepatic sinusoid. Exp Gerontol. 2007;42:374\u20138. https:\/\/doi.org\/10.1016\/j.exger.2006.11.004.","journal-title":"Exp Gerontol"},{"key":"2997_CR83","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1037\/amp0000517","volume":"75","author":"TA Wadden","year":"2020","unstructured":"Wadden TA, Tronieri JS, Butryn ML. Lifestyle modification approaches for the treatment of obesity in adults. Am Psychol. 2020;75:235\u201351. https:\/\/doi.org\/10.1037\/amp0000517.","journal-title":"Am Psychol"},{"key":"2997_CR84","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.3390\/biomedicines13102548","volume":"13","author":"L Jiang","year":"2025","unstructured":"Jiang L, Ding H, Lee D, Chun B. The optimal type and dose of exercise interventions on VEGF levels in healthy individuals, as well as obesity and chronic disease populations: a network meta-analysis. Biomedicines. 2025;13:2548. https:\/\/doi.org\/10.3390\/biomedicines13102548.","journal-title":"Biomedicines"},{"key":"2997_CR85","doi-asserted-by":"publisher","first-page":"1632999","DOI":"10.3389\/fnut.2025.1632999","volume":"12","author":"J Ostaiza-Cardenas","year":"2025","unstructured":"Ostaiza-Cardenas J, et al. Epigenetic modulation by life-style: advances in diet, exercise, and mindfulness for disease prevention and health optimization. Front Nutr. 2025;12:1632999. https:\/\/doi.org\/10.3389\/fnut.2025.1632999.","journal-title":"Front Nutr"},{"issue":"3 Suppl 1","key":"2997_CR86","doi-asserted-by":"publisher","first-page":"647a","DOI":"10.1016\/j.bpj.2022.11.647","volume":"122","author":"P Kelley","year":"2023","unstructured":"Kelley P, Phillips AQ, Canner SW, Wassall SR. Polyunsaturated fatty acids and the effect of phospholipid headgroup on lipid rafts. Biophys J. 2023;122(3 Suppl 1):647a. https:\/\/doi.org\/10.1016\/j.bpj.2022.11.647.","journal-title":"Biophys J"},{"key":"2997_CR87","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.2337\/db23-0070","volume":"72","author":"JY Luo","year":"2023","unstructured":"Luo JY, et al. Induction of KLF2 by exercise activates eNOS to improve vasodilatation in diabetic mice. Diabetes. 2023;72:1330\u201342. https:\/\/doi.org\/10.2337\/db23-0070.","journal-title":"Diabetes"},{"key":"2997_CR88","doi-asserted-by":"publisher","first-page":"156057","DOI":"10.1016\/j.metabol.2024.156057","volume":"161","author":"K Stefanakis","year":"2024","unstructured":"Stefanakis K, Kokkorakis M, Mantzoros CS. The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation. Metabolism. 2024;161:156057. https:\/\/doi.org\/10.1016\/j.metabol.2024.156057.","journal-title":"Metabolism"},{"key":"2997_CR89","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41366-021-00767-9","volume":"45","author":"YH Chang","year":"2021","unstructured":"Chang YH, Yang HY, Shun SC. Effect of exercise intervention dosage on reducing visceral adipose tissue: a systematic review and network meta-analysis of randomized controlled trials. Int J Obes. 2021;45:982\u201397. https:\/\/doi.org\/10.1038\/s41366-021-00767-9.","journal-title":"Int J Obes"},{"key":"2997_CR90","doi-asserted-by":"publisher","first-page":"1409474","DOI":"10.3389\/fendo.2025.1409474","volume":"16","author":"Y Pan","year":"2025","unstructured":"Pan Y, Wang P, Yue C, Liu C. Effect of nine different exercise interventions on insulin sensitivity in diabetic patients: a systematic review and mesh meta-analysis. Front Endocrinol (Lausanne). 2025;16:1409474. https:\/\/doi.org\/10.3389\/fendo.2025.1409474.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2997_CR91","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/emboj.2012.21","volume":"31","author":"GX Ruan","year":"2012","unstructured":"Ruan GX, Kazlauskas A. Axl is essential for VEGF-A-dependent activation of PI3K\/Akt. EMBO J. 2012;31:1692\u2013703. https:\/\/doi.org\/10.1038\/emboj.2012.21.","journal-title":"EMBO J"},{"key":"2997_CR92","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41419-019-1928-z","volume":"10","author":"H Lv","year":"2019","unstructured":"Lv H, et al. Vascular endothelial growth factor 165 inhibits pro-fibrotic differentiation of stromal cells via the DLL4\/Notch4\/smad7 pathway. Cell Death Dis. 2019;10:681. https:\/\/doi.org\/10.1038\/s41419-019-1928-z.","journal-title":"Cell Death Dis"},{"key":"2997_CR93","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","volume":"50","author":"M Fernandez","year":"2009","unstructured":"Fernandez M, et al. Angiogenesis in liver disease. J Hepatol. 2009;50:604\u201320. https:\/\/doi.org\/10.1016\/j.jhep.2008.12.011.","journal-title":"J Hepatol"},{"key":"2997_CR94","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1586\/era.09.6","volume":"9","author":"RS Finn","year":"2009","unstructured":"Finn RS, Zhu AX. Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab. Expert Rev Anticancer Ther. 2009;9:503\u20139. https:\/\/doi.org\/10.1586\/era.09.6.","journal-title":"Expert Rev Anticancer Ther"},{"key":"2997_CR95","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.pharep.2015.04.010","volume":"67","author":"E Maslak","year":"2015","unstructured":"Maslak E, Gregorius A, Chlopicki S. Liver sinusoidal endothelial cells (LSECs) function and NAFLD; NO-based therapy targeted to the liver. Pharmacol Rep. 2015;67:689\u201394. https:\/\/doi.org\/10.1016\/j.pharep.2015.04.010.","journal-title":"Pharmacol Rep"},{"key":"2997_CR96","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1053\/jhep.2003.50383","volume":"38","author":"LD DeLeve","year":"2003","unstructured":"DeLeve LD, et al. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology. 2003;38:900\u20138. https:\/\/doi.org\/10.1053\/jhep.2003.50383.","journal-title":"Hepatology"},{"key":"2997_CR97","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1042\/CS20140125","volume":"127","author":"D Hide","year":"2014","unstructured":"Hide D, et al. A novel form of the human manganese superoxide dismutase protects rat and human livers undergoing ischaemia and reperfusion injury. Clin Sci (Lond). 2014;127:527\u201337. https:\/\/doi.org\/10.1042\/CS20140125.","journal-title":"Clin Sci (Lond)"},{"key":"2997_CR98","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/hep.21080","volume":"43","author":"M Hernandez-Guerra","year":"2006","unstructured":"Hernandez-Guerra M, et al. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension. Hepatology. 2006;43:485\u201391. https:\/\/doi.org\/10.1002\/hep.21080.","journal-title":"Hepatology"},{"key":"2997_CR99","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.niox.2025.03.004","volume":"156","author":"RS Nunes","year":"2025","unstructured":"Nunes RS, Freitas Mariano KC, Pieretti JC, Dos Reis RA, Seabra AB. Innovative nitric oxide-releasing nanomaterials: current progress, trends, challenges, and perspectives in cardiovascular therapies. Nitric Oxide. 2025;156:67\u201381. https:\/\/doi.org\/10.1016\/j.niox.2025.03.004.","journal-title":"Nitric Oxide"},{"key":"2997_CR100","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nature09493","volume":"468","author":"BS Ding","year":"2010","unstructured":"Ding BS, et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature. 2010;468:310\u20135. https:\/\/doi.org\/10.1038\/nature09493.","journal-title":"Nature"},{"key":"2997_CR101","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/ph18060893","volume":"18","author":"J Zhou","year":"2025","unstructured":"Zhou J, Wang J, Zhang L, Zhang C, Tian C. Defenestration of liver sinusoidal endothelial cells: the trigger of liver fibrosis. Pharmaceuticals (Basel). 2025;18:893. https:\/\/doi.org\/10.3390\/ph18060893.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2997_CR102","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/hep.29834","volume":"68","author":"JL Duan","year":"2018","unstructured":"Duan JL, et al. Endothelial Notch activation reshapes the angiocrine of sinusoidal endothelia to aggravate liver fibrosis and blunt regeneration in mice. Hepatology. 2018;68:677\u201390. https:\/\/doi.org\/10.1002\/hep.29834.","journal-title":"Hepatology"},{"key":"2997_CR103","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/ph17050644","volume":"17","author":"Q Wu","year":"2024","unstructured":"Wu Q, et al. Extracellular matrix stiffness-induced mechanotransduction of capillarized liver sinusoidal endothelial cells. Pharmaceuticals (Basel). 2024;17:644. https:\/\/doi.org\/10.3390\/ph17050644.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2997_CR104","doi-asserted-by":"publisher","first-page":"e18832","DOI":"10.1002\/adma.202518832","volume":"38","author":"S Liu","year":"2026","unstructured":"Liu S, et al. Ultrasound-responsive dual-prodrug nanoassembly for \u201cfenestrae-restoration strategy\u201d in liver fibrosis therapy. Adv Mater. 2026;38:e18832. https:\/\/doi.org\/10.1002\/adma.202518832.","journal-title":"Adv Mater"},{"key":"2997_CR105","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3389\/fphys.2020.00755","volume":"11","author":"M Kitada","year":"2020","unstructured":"Kitada M, Xu J, Ogura Y, Monno I, Koya D. Manganese superoxide dismutase dysfunction and the pathogenesis of kidney disease. Front Physiol. 2020;11:755. https:\/\/doi.org\/10.3389\/fphys.2020.00755.","journal-title":"Front Physiol"},{"key":"2997_CR106","doi-asserted-by":"publisher","first-page":"205031212211053","DOI":"10.1177\/20503121221105330","volume":"10","author":"P Vahedi","year":"2022","unstructured":"Vahedi P, Rajabzadeh A, Soleimani A. An evaluation of the effects of ascorbic acid on the endothelium of coronary and aorta arteries in lead-intoxicated rabbits. SAGE Open Med. 2022;10:20503121221105330. https:\/\/doi.org\/10.1177\/20503121221105330.","journal-title":"SAGE Open Med"},{"key":"2997_CR107","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/liv.12231","volume":"33","author":"L Venkatraman","year":"2013","unstructured":"Venkatraman L, Tucker-Kellogg L. The CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cells. Liver Int. 2013;33:1386\u201397. https:\/\/doi.org\/10.1111\/liv.12231.","journal-title":"Liver Int"},{"key":"2997_CR108","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.jhep.2013.02.005","volume":"58","author":"J Gracia-Sancho","year":"2013","unstructured":"Gracia-Sancho J, et al. Simvastatin maintains function and viability of steatotic rat livers procured for transplantation. J Hepatol. 2013;58:1140\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2013.02.005.","journal-title":"J Hepatol"},{"key":"2997_CR109","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/gerona\/glz012","volume":"75","author":"D Hide","year":"2020","unstructured":"Hide D, et al. Ischemia\/reperfusion injury in the aged liver: the importance of the sinusoidal endothelium in developing therapeutic strategies for the elderly. J Gerontol A Biol Sci Med Sci. 2020;75:268\u201377. https:\/\/doi.org\/10.1093\/gerona\/glz012.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2997_CR110","doi-asserted-by":"publisher","first-page":"22107","DOI":"10.1038\/srep22107","volume":"6","author":"D Hide","year":"2016","unstructured":"Hide D, et al. Effects of warm ischemia and reperfusion on the liver microcirculatory phenotype of rats: underlying mechanisms and pharmacological therapy. Sci Rep. 2016;6:22107. https:\/\/doi.org\/10.1038\/srep22107.","journal-title":"Sci Rep"},{"key":"2997_CR111","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1111\/liv.12827","volume":"35","author":"H Ajamieh","year":"2015","unstructured":"Ajamieh H, et al. Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation. Liver Int. 2015;35:2174\u201386. https:\/\/doi.org\/10.1111\/liv.12827.","journal-title":"Liver Int"},{"key":"2997_CR112","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/MEG.0000000000002517","volume":"35","author":"J Zhang","year":"2023","unstructured":"Zhang J, Fu S, Liu D, Wang Y, Tan Y. Statin can reduce the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2023;35:353\u20138. https:\/\/doi.org\/10.1097\/MEG.0000000000002517.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2997_CR113","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"European Association for the Study of the Liver","year":"2024","unstructured":"European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81:492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031.","journal-title":"J Hepatol."},{"key":"2997_CR114","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797\u2013835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323.","journal-title":"Hepatology"},{"key":"2997_CR115","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3390\/ijms19041197","volume":"19","author":"M Botta","year":"2018","unstructured":"Botta M, et al. PPAR agonists and metabolic syndrome: an established role? Int J Mol Sci. 2018;19:1197. https:\/\/doi.org\/10.3390\/ijms19041197.","journal-title":"Int J Mol Sci"},{"key":"2997_CR116","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","volume":"385","author":"SM Francque","year":"2021","unstructured":"Francque SM, et al. A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH. N Engl J Med. 2021;385:1547\u201358. https:\/\/doi.org\/10.1056\/NEJMoa2036205.","journal-title":"N Engl J Med"},{"key":"2997_CR117","doi-asserted-by":"publisher","first-page":"e186425","DOI":"10.1172\/JCI186425","volume":"135","author":"PN Newsome","year":"2025","unstructured":"Newsome PN, Loomba R. Therapeutic horizons in metabolic dysfunction-associated steatohepatitis. J Clin Invest. 2025;135:e186425. https:\/\/doi.org\/10.1172\/JCI186425.","journal-title":"J Clin Invest"},{"key":"2997_CR118","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1038\/s41467-024-47919-9","volume":"15","author":"MP Cooreman","year":"2024","unstructured":"Cooreman MP, et al. The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis. Nat Commun. 2024;15:3962. https:\/\/doi.org\/10.1038\/s41467-024-47919-9.","journal-title":"Nat Commun"},{"key":"2997_CR119","doi-asserted-by":"publisher","first-page":"101366","DOI":"10.1016\/j.jhepr.2025.101366","volume":"7","author":"PE Rautou","year":"2025","unstructured":"Rautou PE, et al. Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment. JHEP Rep. 2025;7:101366. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101366.","journal-title":"JHEP Rep"},{"key":"2997_CR120","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jhep.2023.07.004","volume":"79","author":"B Staels","year":"2023","unstructured":"Staels B, Butruille L, Francque S. Treating NASH by targeting peroxisome proliferator-activated receptors. J Hepatol. 2023;79:1302\u201316. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.004.","journal-title":"J Hepatol"},{"key":"2997_CR121","doi-asserted-by":"publisher","first-page":"e0005","DOI":"10.1097\/HC9.0000000000000005","volume":"7","author":"CH Ng","year":"2023","unstructured":"Ng CH, et al. Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals. Hepatol Commun. 2023;7:e0005. https:\/\/doi.org\/10.1097\/HC9.0000000000000005.","journal-title":"Hepatol Commun"},{"key":"2997_CR122","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1097\/HEP.0000000000001254","volume":"82","author":"M Souza","year":"2025","unstructured":"Souza M, Al-Sharif L, Antunes VLJ, Huang DQ, Loomba R. Comparison of pharmacological therapies in metabolic dysfunction-associated steatohepatitis for fibrosis regression and MASH resolution: systematic review and network meta-analysis. Hepatology. 2025;82:1523\u201333. https:\/\/doi.org\/10.1097\/HEP.0000000000001254.","journal-title":"Hepatology"},{"key":"2997_CR123","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.eprac.2024.12.017","volume":"31","author":"ABM Kamrul-Hasan","year":"2025","unstructured":"Kamrul-Hasan ABM, et al. Neuropsychiatric effects of tirzepatide: a systematic review and meta-analysis. Endocr Pract. 2025;31:703\u20136. https:\/\/doi.org\/10.1016\/j.eprac.2024.12.017.","journal-title":"Endocr Pract"},{"key":"2997_CR124","doi-asserted-by":"publisher","first-page":"1534628","DOI":"10.3389\/fphar.2025.1534628","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhao X, Wang X, Zhou Q. Adverse events of hepatic anti-fibrotic agents in phase 3 and above clinical trials: a descriptive analysis of the WHO-VigiAccess database. Front Pharmacol. 2025;16:1534628. https:\/\/doi.org\/10.3389\/fphar.2025.1534628.","journal-title":"Front Pharmacol"},{"key":"2997_CR125","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/MEG.0000000000002892","volume":"37","author":"M Talha","year":"2025","unstructured":"Talha M, et al. Efficacy and safety of resmetirom for the treatment of nonalcoholic steatohepatitis: a GRADE assessed systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2025;37:247\u201356. https:\/\/doi.org\/10.1097\/MEG.0000000000002892.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2997_CR126","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/pharma4030014","volume":"4","author":"J Udaikumar","year":"2025","unstructured":"Udaikumar J, et al. The comparative safety and efficacy of resmetirom and semaglutide in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review. Pharmacoepidemiology. 2025;4:14. https:\/\/doi.org\/10.3390\/pharma4030014.","journal-title":"Pharmacoepidemiology"},{"key":"2997_CR127","doi-asserted-by":"publisher","first-page":"101433","DOI":"10.37349\/eemd.2025.101433","volume":"2","author":"R Zhang","year":"2025","unstructured":"Zhang R, et al. Comparative pharmacodynamic analysis of resmetirom, semaglutide and obeticholic acid in translational mouse models of MASH. Explor Endocr Metab Dis. 2025;2:101433. https:\/\/doi.org\/10.37349\/eemd.2025.101433.","journal-title":"Explor Endocr Metab Dis."},{"key":"2997_CR128","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1172\/JCI200421025","volume":"113","author":"M Watanabe","year":"2004","unstructured":"Watanabe M, et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest. 2004;113:1408\u201318. https:\/\/doi.org\/10.1172\/JCI200421025.","journal-title":"J Clin Invest"},{"key":"2997_CR129","doi-asserted-by":"publisher","first-page":"247ra100","DOI":"10.1126\/scitranslmed.3009098","volume":"6","author":"J Luo","year":"2014","unstructured":"Luo J, et al. A nontumorigenic variant of FGF19 treats cholestatic liver diseases. Sci Transl Med. 2014;6:247ra100. https:\/\/doi.org\/10.1126\/scitranslmed.3009098.","journal-title":"Sci Transl Med."},{"key":"2997_CR130","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jhep.2023.07.014","volume":"79","author":"AJ Sanyal","year":"2023","unstructured":"Sanyal AJ, et al. Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis. J Hepatol. 2023;79:1110\u201320. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.014.","journal-title":"J Hepatol"},{"key":"2997_CR131","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","volume":"394","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, et al. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2019;394:2184\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(19)33041-7.","journal-title":"Lancet"},{"key":"2997_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.01.069","volume":"595","author":"L Jiang","year":"2022","unstructured":"Jiang L, et al. Structural insight into the molecular mechanism of cilofexor binding to the farnesoid X receptor. Biochem Biophys Res Commun. 2022;595:1\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2022.01.069.","journal-title":"Biochem Biophys Res Commun"},{"key":"2997_CR133","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41591-022-02200-8","volume":"29","author":"AJ Sanyal","year":"2023","unstructured":"Sanyal AJ, et al. Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a\/b trial. Nat Med. 2023;29:392\u2013400. https:\/\/doi.org\/10.1038\/s41591-022-02200-8.","journal-title":"Nat Med"},{"key":"2997_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118332","volume":"302","author":"Q Li","year":"2026","unstructured":"Li Q, et al. FXR-targeted drug discovery: recent advances and therapeutic perspectives. Eur J Med Chem. 2026;302:118332. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118332.","journal-title":"Eur J Med Chem"},{"key":"2997_CR135","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/hep.23476","volume":"51","author":"H Yin","year":"2010","unstructured":"Yin H, et al. Lactoferrin protects against acetaminophen-induced liver injury in mice. Hepatology. 2010;51:1007\u201316. https:\/\/doi.org\/10.1002\/hep.23476.","journal-title":"Hepatology"},{"key":"2997_CR136","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/hep.31179","volume":"72","author":"X Wang","year":"2020","unstructured":"Wang X, et al. Susceptibility of rat steatotic liver to ischemia-reperfusion is treatable with liver-selective matrix metalloproteinase inhibition. Hepatology. 2020;72:1771\u201385. https:\/\/doi.org\/10.1002\/hep.31179.","journal-title":"Hepatology"},{"key":"2997_CR137","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/hep.30169","volume":"69","author":"X Wang","year":"2019","unstructured":"Wang X, Maretti-Mira AC, Wang L, DeLeve LD. Liver-selective MMP-9 inhibition in the rat eliminates ischemia-reperfusion injury and accelerates liver regeneration. Hepatology. 2019;69:314\u201328. https:\/\/doi.org\/10.1002\/hep.30169.","journal-title":"Hepatology"},{"key":"2997_CR138","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jhep.2014.10.007","volume":"62","author":"G Mandili","year":"2015","unstructured":"Mandili G, et al. Mouse hepatocytes and LSEC proteome reveal novel mechanisms of ischemia\/reperfusion damage and protection by A2aR stimulation. J Hepatol. 2015;62:573\u201380. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.007.","journal-title":"J Hepatol"},{"key":"2997_CR139","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.21873\/invivo.11393","volume":"32","author":"S Takada","year":"2018","unstructured":"Takada S, et al. Soluble thrombomodulin attenuates endothelial cell damage in hepatic sinusoidal obstruction syndrome. In Vivo. 2018;32:1409\u201317. https:\/\/doi.org\/10.21873\/invivo.11393.","journal-title":"In Vivo"},{"key":"2997_CR140","doi-asserted-by":"publisher","first-page":"113242","DOI":"10.1016\/j.matdes.2024.113242","volume":"245","author":"S Chen","year":"2024","unstructured":"Chen S, Jin L, Zeng Z, Chen G. Nanoparticle-based delivery system for normalization of liver sinusoidal endothelial cells in hepatocellular carcinoma. Mater Des. 2024;245:113242. https:\/\/doi.org\/10.1016\/j.matdes.2024.113242.","journal-title":"Mater Des"},{"key":"2997_CR141","doi-asserted-by":"publisher","first-page":"14029","DOI":"10.1021\/acsnano.2c03858","volume":"16","author":"LF Zhang","year":"2022","unstructured":"Zhang LF, et al. Sequential nano-penetrators of capillarized liver sinusoids and extracellular matrix barriers for liver fibrosis therapy. ACS Nano. 2022;16:14029\u201342. https:\/\/doi.org\/10.1021\/acsnano.2c03858.","journal-title":"ACS Nano"},{"key":"2997_CR142","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ijc.31343","volume":"143","author":"J Marquez","year":"2018","unstructured":"Marquez J, et al. Targeting liver sinusoidal endothelial cells with miR-20a-loaded nanoparticles reduces murine colon cancer metastasis to the liver. Int J Cancer. 2018;143:709\u201319. https:\/\/doi.org\/10.1002\/ijc.31343.","journal-title":"Int J Cancer"},{"issue":"5","key":"2997_CR143","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1002\/mco2.721","volume":"2024","author":"Z Dong","year":"2020","unstructured":"Dong Z, Wang Y, Jin W. Liver cirrhosis: molecular mechanisms and therapeutic interventions. MedComm. 2020;2024(5):e721. https:\/\/doi.org\/10.1002\/mco2.721.","journal-title":"MedComm"},{"key":"2997_CR144","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1038\/s41467-025-59885-x","volume":"16","author":"W Liu","year":"2025","unstructured":"Liu W, et al. Nucleic acid spheres for treating capillarisation of liver sinusoidal endothelial cells in liver fibrosis. Nat Commun. 2025;16:4517. https:\/\/doi.org\/10.1038\/s41467-025-59885-x.","journal-title":"Nat Commun"},{"key":"2997_CR145","doi-asserted-by":"publisher","first-page":"100117","DOI":"10.1016\/j.asems.2024.100117","volume":"3","author":"C Xia","year":"2024","unstructured":"Xia C, et al. Spherical nucleic acids for biomedical applications. Adv Sens Energy Mater. 2024;3:100117. https:\/\/doi.org\/10.1016\/j.asems.2024.100117.","journal-title":"Adv Sens Energy Mater"},{"key":"2997_CR146","doi-asserted-by":"publisher","first-page":"108004","DOI":"10.1016\/j.pharmthera.2021.108004","volume":"232","author":"L Zhang","year":"2022","unstructured":"Zhang L, et al. Stem cell therapy in liver regeneration: focus on mesenchymal stem cells and induced pluripotent stem cells. Pharmacol Ther. 2022;232:108004. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108004.","journal-title":"Pharmacol Ther"},{"issue":"Suppl 1","key":"2997_CR147","doi-asserted-by":"publisher","first-page":"S442","DOI":"10.1016\/S0168-8278(23)01129-7","volume":"78","author":"SJ Park","year":"2023","unstructured":"Park SJ, et al. Hepatic progenitor cell activation through the interaction of mesenchymal stem cells and liver sinusoidal endothelial cells. J Hepatol. 2023;78(Suppl 1):S442. https:\/\/doi.org\/10.1016\/S0168-8278(23)01129-7.","journal-title":"J Hepatol"},{"key":"2997_CR148","doi-asserted-by":"publisher","first-page":"101023","DOI":"10.1016\/j.jhepr.2024.101023","volume":"6","author":"KK Yap","year":"2024","unstructured":"Yap KK, et al. Liver specification of human iPSC-derived endothelial cells transplanted into mouse liver. JHEP Rep. 2024;6:101023. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101023.","journal-title":"JHEP Rep"},{"key":"2997_CR149","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/gels8120829","volume":"8","author":"X Huang","year":"2022","unstructured":"Huang X, et al. Current advances in 3D dynamic cell culture systems. Gels. 2022;8:829. https:\/\/doi.org\/10.3390\/gels8120829.","journal-title":"Gels"},{"key":"2997_CR150","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/bit.25700","volume":"113","author":"L Prodanov","year":"2016","unstructured":"Prodanov L, et al. Long-term maintenance of a microfluidic 3D human liver sinusoid. Biotechnol Bioeng. 2016;113:241\u20136. https:\/\/doi.org\/10.1002\/bit.25700.","journal-title":"Biotechnol Bioeng"},{"key":"2997_CR151","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1136\/gutjnl-2019-319256","volume":"68","author":"N Prior","year":"2019","unstructured":"Prior N, Inacio P, Huch M. Liver organoids: from basic research to therapeutic applications. Gut. 2019;68:2228\u201337. https:\/\/doi.org\/10.1136\/gutjnl-2019-319256.","journal-title":"Gut"},{"key":"2997_CR152","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","volume":"2","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, et al. Organoids Nat Rev Methods Primers. 2022;2:94. https:\/\/doi.org\/10.1038\/s43586-022-00174-y.","journal-title":"Organoids Nat Rev Methods Primers"},{"key":"2997_CR153","doi-asserted-by":"publisher","first-page":"061502","DOI":"10.1063\/5.0106855","volume":"16","author":"Z Yang","year":"2022","unstructured":"Yang Z, et al. Liver-on-a-chip: considerations, advances, and beyond. Biomicrofluidics. 2022;16:061502. https:\/\/doi.org\/10.1063\/5.0106855.","journal-title":"Biomicrofluidics"},{"key":"2997_CR154","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s44222-024-00207-z","volume":"2","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, et al. Integrating organoids and organ-on-a-chip devices. Nat Rev Bioeng. 2024;2:588\u2013608. https:\/\/doi.org\/10.1038\/s44222-024-00207-z.","journal-title":"Nat Rev Bioeng"},{"key":"2997_CR155","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jcmgh.2022.11.008","volume":"15","author":"S Kaur","year":"2023","unstructured":"Kaur S, et al. In vitro models for the study of liver biology and diseases: advances and limitations. Cell Mol Gastroenterol Hepatol. 2023;15:559\u201371. https:\/\/doi.org\/10.1016\/j.jcmgh.2022.11.008.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2997_CR156","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/liv.14942","volume":"41","author":"MA Polidoro","year":"2021","unstructured":"Polidoro MA, Ferrari E, Marzorati S, Lleo A, Rasponi M. Experimental liver models: from cell culture techniques to microfluidic organs-on-chip. Liver Int. 2021;41:1744\u201361. https:\/\/doi.org\/10.1111\/liv.14942.","journal-title":"Liver Int"},{"key":"2997_CR157","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1152\/physiol.00036.2016","volume":"32","author":"K Duval","year":"2017","unstructured":"Duval K, et al. Modeling physiological events in 2D vs. 3D cell culture. Physiology. 2017;32:266\u201377. https:\/\/doi.org\/10.1152\/physiol.00036.2016.","journal-title":"Physiology."},{"key":"2997_CR158","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/gutjnl-2011-301494","volume":"62","author":"G Xie","year":"2013","unstructured":"Xie G, et al. Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation. Gut. 2013;62:299\u2013309. https:\/\/doi.org\/10.1136\/gutjnl-2011-301494.","journal-title":"Gut"},{"key":"2997_CR159","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/01.tp.0000124286.82961.7e","volume":"77","author":"T Matsumura","year":"2004","unstructured":"Matsumura T, et al. Establishment of an immortalized human-liver endothelial cell line with SV40T and hTERT. Transplantation. 2004;77:1357\u201365. https:\/\/doi.org\/10.1097\/01.tp.0000124286.82961.7e.","journal-title":"Transplantation"},{"key":"2997_CR160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-4827(91)90492-d","volume":"195","author":"S Hering","year":"1991","unstructured":"Hering S, Griffin BE, Strauss M. Immortalization of human fetal sinusoidal liver cells by polyoma virus large T antigen. Exp Cell Res. 1991;195:1\u20137. https:\/\/doi.org\/10.1016\/0014-4827(91)90492-d.","journal-title":"Exp Cell Res"},{"key":"2997_CR161","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2014.05.038","volume":"450","author":"R Parent","year":"2014","unstructured":"Parent R, et al. An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endothelium. Biochem Biophys Res Commun. 2014;450:7\u201312. https:\/\/doi.org\/10.1016\/j.bbrc.2014.05.038.","journal-title":"Biochem Biophys Res Commun"},{"key":"2997_CR162","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/labinvest.2010.132","volume":"90","author":"RC Huebert","year":"2010","unstructured":"Huebert RC, et al. Immortalized liver endothelial cells: a cell culture model for studies of motility and angiogenesis. Lab Invest. 2010;90:1770\u201381. https:\/\/doi.org\/10.1038\/labinvest.2010.132.","journal-title":"Lab Invest"},{"key":"2997_CR163","doi-asserted-by":"publisher","first-page":"G137","DOI":"10.1152\/ajpgi.00069.2008","volume":"295","author":"VC Cogger","year":"2008","unstructured":"Cogger VC, et al. The response of fenestrations, actin, and caveolin-1 to vascular endothelial growth factor in SK Hep1 cells. Am J Physiol Gastrointest Liver Physiol. 2008;295:G137\u201345. https:\/\/doi.org\/10.1152\/ajpgi.00069.2008.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2997_CR164","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3892\/ijmm.2015.2067","volume":"35","author":"X Zhao","year":"2015","unstructured":"Zhao X, et al. Spontaneous immortalization of mouse liver sinusoidal endothelial cells. Int J Mol Med. 2015;35:617\u201324. https:\/\/doi.org\/10.3892\/ijmm.2015.2067.","journal-title":"Int J Mol Med"},{"key":"2997_CR165","first-page":"2931","volume":"11","author":"Y Tai","year":"2018","unstructured":"Tai Y, et al. SK-Hep1: not hepatocellular carcinoma cells but a cell model for liver sinusoidal endothelial cells. Int J Clin Exp Pathol. 2018;11:2931\u20138.","journal-title":"Int J Clin Exp Pathol"},{"key":"2997_CR166","doi-asserted-by":"publisher","first-page":"13831","DOI":"10.1038\/s41598-024-64195-1","volume":"14","author":"SP Tian","year":"2024","unstructured":"Tian SP, et al. A novel efficient strategy to generate liver sinusoidal endothelial cells from human pluripotent stem cells. Sci Rep. 2024;14:13831. https:\/\/doi.org\/10.1038\/s41598-024-64195-1.","journal-title":"Sci Rep"},{"key":"2997_CR167","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/HEP.0000000000001018","volume":"81","author":"U Ojha","year":"2025","unstructured":"Ojha U, et al. Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis. Hepatology. 2025;81:1228\u201343. https:\/\/doi.org\/10.1097\/HEP.0000000000001018.","journal-title":"Hepatology"},{"key":"2997_CR168","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jcmgh.2020.12.007","volume":"11","author":"T Su","year":"2021","unstructured":"Su T, et al. Single-cell transcriptomics reveals zone-specific alterations of liver sinusoidal endothelial cells in cirrhosis. Cell Mol Gastroenterol Hepatol. 2021;11:1139\u201361. https:\/\/doi.org\/10.1016\/j.jcmgh.2020.12.007.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2997_CR169","doi-asserted-by":"publisher","first-page":"e2411667","DOI":"10.1002\/advs.202411667","volume":"12","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, et al. hESCs-derived organoids achieve liver zonation features through LSEC modulation. Adv Sci (Weinh). 2025;12:e2411667. https:\/\/doi.org\/10.1002\/advs.202411667.","journal-title":"Adv Sci (Weinh)"},{"key":"2997_CR170","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","volume":"10","author":"C Lee","year":"2025","unstructured":"Lee C, et al. Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Signal Transduct Target Ther. 2025;10:170. https:\/\/doi.org\/10.1038\/s41392-025-02249-0.","journal-title":"Signal Transduct Target Ther"},{"key":"2997_CR171","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.21785","volume":"46","author":"M Fernandez","year":"2007","unstructured":"Fernandez M, et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology. 2007;46:1208\u201317. https:\/\/doi.org\/10.1002\/hep.21785.","journal-title":"Hepatology"},{"key":"2997_CR172","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, et al. Hepatocellular carcinoma Nat Rev Dis Primers. 2021;7:6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3.","journal-title":"Hepatocellular carcinoma Nat Rev Dis Primers"},{"key":"2997_CR173","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1089\/hum.2018.069","volume":"29","author":"X Liang","year":"2018","unstructured":"Liang X, Liu L, Wei YQ, Gao GP, Wei XW. Clinical evaluations of toxicity and efficacy of nanoparticle-mediated gene therapy. Hum Gene Ther. 2018;29:1227\u201334. https:\/\/doi.org\/10.1089\/hum.2018.069.","journal-title":"Hum Gene Ther"},{"key":"2997_CR174","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","volume":"24","author":"L Perez-Gutierrez","year":"2023","unstructured":"Perez-Gutierrez L, Ferrara N. Biology and therapeutic targeting of vascular endothelial growth factor A. Nat Rev Mol Cell Biol. 2023;24:816\u201334. https:\/\/doi.org\/10.1038\/s41580-023-00631-w.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2997_CR175","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2174\/2211738507666190429111306","volume":"7","author":"H Alimoradi","year":"2019","unstructured":"Alimoradi H, Greish K, Gamble AB, Giles GI. Controlled delivery of nitric oxide for cancer therapy. Pharm Nanotechnol. 2019;7:279\u2013303. https:\/\/doi.org\/10.2174\/2211738507666190429111306.","journal-title":"Pharm Nanotechnol"},{"key":"2997_CR176","doi-asserted-by":"publisher","first-page":"215052","DOI":"10.1016\/j.ccr.2023.215052","volume":"481","author":"GR Navale","year":"2023","unstructured":"Navale GR, Singh S, Ghosh K. NO donors as the wonder molecules with therapeutic potential: recent trends and future perspectives. Coord Chem Rev. 2023;481:215052. https:\/\/doi.org\/10.1016\/j.ccr.2023.215052.","journal-title":"Coord Chem Rev"},{"key":"2997_CR177","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.3390\/ijms26093988","volume":"26","author":"M Puri","year":"2025","unstructured":"Puri M, Sonawane S. Liver sinusoidal endothelial cells in the regulation of immune responses and fibrosis in metabolic dysfunction-associated fatty liver disease. Int J Mol Sci. 2025;26:3988. https:\/\/doi.org\/10.3390\/ijms26093988.","journal-title":"Int J Mol Sci"},{"key":"2997_CR178","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10456-021-09780-y","volume":"24","author":"PS Koch","year":"2021","unstructured":"Koch PS, Lee KH, Goerdt S, Augustin HG. Angiodiversity and organotypic functions of sinusoidal endothelial cells. Angiogenesis. 2021;24:289\u2013310. https:\/\/doi.org\/10.1007\/s10456-021-09780-y.","journal-title":"Angiogenesis"},{"key":"2997_CR179","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.jhep.2022.08.028","volume":"77","author":"EK Mitten","year":"2022","unstructured":"Mitten EK, Baffy G. Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2022;77:1642\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.028.","journal-title":"J Hepatol"},{"key":"2997_CR180","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jhep.2022.03.029","volume":"77","author":"T Greuter","year":"2022","unstructured":"Greuter T, et al. Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo. J Hepatol. 2022;77:723\u201334. https:\/\/doi.org\/10.1016\/j.jhep.2022.03.029.","journal-title":"J Hepatol"},{"key":"2997_CR181","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41586-024-07372-6","volume":"629","author":"Y Miyamoto","year":"2024","unstructured":"Miyamoto Y, et al. Periportal macrophages protect against commensal-driven liver inflammation. Nature. 2024;629:901\u20139. https:\/\/doi.org\/10.1038\/s41586-024-07372-6.","journal-title":"Nature"},{"key":"2997_CR182","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-540-93842-2_9","volume-title":"Clinical hepatology","author":"H Dancygier","year":"2010","unstructured":"Dancygier H. Chapter 9. In: Clinical hepatology. Berlin: Springer; 2010. p. 131\u20136."},{"key":"2997_CR183","doi-asserted-by":"publisher","first-page":"101475","DOI":"10.1016\/j.jcmgh.2025.101475","volume":"19","author":"S Ma","year":"2025","unstructured":"Ma S, et al. Congestion enriches intra-hepatic macrophages through reverse zonation of CXCL9 in liver sinusoidal endothelial cells. Cell Mol Gastroenterol Hepatol. 2025;19:101475. https:\/\/doi.org\/10.1016\/j.jcmgh.2025.101475.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2997_CR184","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s11658-025-00798-4","volume":"30","author":"J Wang","year":"2025","unstructured":"Wang J, et al. YAP contributes to liver injury through mediating capillarization of liver sinusoidal endothelial cells via GATA6\/eNOS signaling. Cell Mol Biol Lett. 2025;30:119. https:\/\/doi.org\/10.1186\/s11658-025-00798-4.","journal-title":"Cell Mol Biol Lett"},{"key":"2997_CR185","doi-asserted-by":"publisher","first-page":"671081","DOI":"10.3389\/fcell.2021.671081","volume":"9","author":"B Ruan","year":"2021","unstructured":"Ruan B, et al. Capillarized liver sinusoidal endothelial cells undergo partial endothelial-mesenchymal transition to actively deposit sinusoidal ECM in liver fibrosis. Front Cell Dev Biol. 2021;9:671081. https:\/\/doi.org\/10.3389\/fcell.2021.671081.","journal-title":"Front Cell Dev Biol"},{"key":"2997_CR186","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/ijtm4020012","volume":"4","author":"M Puri","year":"2024","unstructured":"Puri M. Spatial computational hepatic molecular biomarker reveals LSEC role in midlobular liver zonation fibrosis in DILI and NASH liver injury. Int J Transl Med. 2024;4:208\u201323. https:\/\/doi.org\/10.3390\/ijtm4020012.","journal-title":"Int J Transl Med"},{"key":"2997_CR187","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41536-024-00361-3","volume":"9","author":"C Ashmore-Harris","year":"2024","unstructured":"Ashmore-Harris C, et al. Exploiting in silico modelling to enhance translation of liver cell therapies from bench to bedside. NPJ Regen Med. 2024;9:19. https:\/\/doi.org\/10.1038\/s41536-024-00361-3.","journal-title":"NPJ Regen Med"},{"key":"2997_CR188","doi-asserted-by":"publisher","first-page":"e10298","DOI":"10.1016\/j.heliyon.2022.e10298","volume":"8","author":"K Ma","year":"2022","unstructured":"Ma K, Chen X, Zhao X, Chen S, Yang J. PLVAP is associated with glioma-associated malignant processes and immunosuppressive cell infiltration as a promising marker for prognosis. Heliyon. 2022;8:e10298. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10298.","journal-title":"Heliyon"},{"key":"2997_CR189","doi-asserted-by":"publisher","first-page":"1143157","DOI":"10.3389\/fbioe.2023.1143157","volume":"11","author":"C Guo","year":"2023","unstructured":"Guo C, Ma X, Gao F, Guo Y. Off-target effects in CRISPR\/Cas9 gene editing. Front Bioeng Biotechnol. 2023;11:1143157. https:\/\/doi.org\/10.3389\/fbioe.2023.1143157.","journal-title":"Front Bioeng Biotechnol"},{"key":"2997_CR190","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.ymthe.2018.04.018","volume":"26","author":"L Gailhouste","year":"2018","unstructured":"Gailhouste L, et al. Differentiation therapy by epigenetic reconditioning exerts antitumor effects on liver cancer cells. Mol Ther. 2018;26:1840\u201354. https:\/\/doi.org\/10.1016\/j.ymthe.2018.04.018.","journal-title":"Mol Ther"},{"key":"2997_CR191","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.tibtech.2024.02.007","volume":"42","author":"T Clark","year":"2024","unstructured":"Clark T, et al. CRISPR activation screens: navigating technologies and applications. Trends Biotechnol. 2024;42:1017\u201334. https:\/\/doi.org\/10.1016\/j.tibtech.2024.02.007.","journal-title":"Trends Biotechnol"},{"key":"2997_CR192","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1089\/hum.2015.069","volume":"26","author":"L Li","year":"2015","unstructured":"Li L, He ZY, Wei XW, Gao GP, Wei YQ. Challenges in CRISPR\/CAS9 delivery: potential roles of nonviral vectors. Hum Gene Ther. 2015;26:452\u201362. https:\/\/doi.org\/10.1089\/hum.2015.069.","journal-title":"Hum Gene Ther"},{"key":"2997_CR193","doi-asserted-by":"publisher","first-page":"12996","DOI":"10.18632\/aging.202973","volume":"13","author":"W Li","year":"2021","unstructured":"Li W, et al. Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2. Aging (Albany NY). 2021;13:12996\u20133005. https:\/\/doi.org\/10.18632\/aging.202973.","journal-title":"Aging (Albany NY)."},{"key":"2997_CR194","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fphys.2019.00006","volume":"10","author":"E Kus","year":"2019","unstructured":"Kus E, et al. LSEC fenestrae are preserved despite pro-inflammatory phenotype of liver sinusoidal endothelial cells in mice on high fat diet. Front Physiol. 2019;10:6. https:\/\/doi.org\/10.3389\/fphys.2019.00006.","journal-title":"Front Physiol"},{"key":"2997_CR195","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s44161-024-00487-z","volume":"3","author":"D Eberhard","year":"2024","unstructured":"Eberhard D, et al. Semaphorin-3A regulates liver sinusoidal endothelial cell porosity and promotes hepatic steatosis. Nat Cardiovasc Res. 2024;3:734\u201353. https:\/\/doi.org\/10.1038\/s44161-024-00487-z.","journal-title":"Nat Cardiovasc Res"},{"key":"2997_CR196","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13578-025-01411-z","volume":"15","author":"Y Min","year":"2025","unstructured":"Min Y, et al. Post-translational modifications in the pathophysiological process of metabolic dysfunction-associated steatotic liver disease. Cell Biosci. 2025;15:53. https:\/\/doi.org\/10.1186\/s13578-025-01411-z.","journal-title":"Cell Biosci"},{"key":"2997_CR197","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4093\/dmj.2025.0195","volume":"49","author":"YJ Roh","year":"2025","unstructured":"Roh YJ, Kim H, Choi DW. Metabolic sparks in the liver: metabolic and epigenetic reprogramming in hepatic stellate cells activation and its implications for human metabolic diseases. Diabetes Metab J. 2025;49:368\u201385. https:\/\/doi.org\/10.4093\/dmj.2025.0195.","journal-title":"Diabetes Metab J"},{"key":"2997_CR198","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/2211-5463.13405","volume":"12","author":"Z Huang","year":"2022","unstructured":"Huang Z, Khalifa MO, Gu W, Li TS. Hydrostatic pressure induces profibrotic properties in hepatic stellate cells via the RhoA\/ROCK signaling pathway. FEBS Open Bio. 2022;12:1230\u201340. https:\/\/doi.org\/10.1002\/2211-5463.13405.","journal-title":"FEBS Open Bio"},{"key":"2997_CR199","doi-asserted-by":"publisher","unstructured":"Ma J, et al. Liver stiffness rises early in MASLD and drives inflammation, lipid dysmetabolism, and fibrosis via Piezo1-YAP mechanotransduction. Adv Sci (Weinh). 2026;in press. https:\/\/doi.org\/10.1002\/advs.202519109.","DOI":"10.1002\/advs.202519109"},{"key":"2997_CR200","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1038\/s41467-024-49545-x","volume":"15","author":"AA Raslan","year":"2024","unstructured":"Raslan AA, et al. Lung injury-induced activated endothelial cell states persist in aging-associated progressive fibrosis. Nat Commun. 2024;15:5449. https:\/\/doi.org\/10.1038\/s41467-024-49545-x.","journal-title":"Nat Commun"},{"key":"2997_CR201","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41575-023-00796-x","volume":"20","author":"PN Brennan","year":"2023","unstructured":"Brennan PN, et al. Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach. Nat Rev Gastroenterol Hepatol. 2023;20:679\u201388. https:\/\/doi.org\/10.1038\/s41575-023-00796-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2997_CR202","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/his.14083","volume":"76","author":"X Zhang","year":"2020","unstructured":"Zhang X, et al. Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy. Histopathology. 2020;76:959\u201367. https:\/\/doi.org\/10.1111\/his.14083.","journal-title":"Histopathology"},{"key":"2997_CR203","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/liv.13639","volume":"38","author":"KJ Thompson","year":"2018","unstructured":"Thompson KJ, et al. Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma. Liver Int. 2018;38:1074\u201383. https:\/\/doi.org\/10.1111\/liv.13639.","journal-title":"Liver Int"},{"issue":"Suppl 1","key":"2997_CR204","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.jceh.2023.07.393","volume":"13","author":"S Baidya","year":"2023","unstructured":"Baidya S, et al. Rise in serum hyaluronic acid, marker of liver sinusoidal endothelial injury, correlates with adverse outcome in patients with rodenticidal hepatotoxicity. J Clin Exp Hepatol. 2023;13(Suppl 1):S9. https:\/\/doi.org\/10.1016\/j.jceh.2023.07.393.","journal-title":"J Clin Exp Hepatol"},{"key":"2997_CR205","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1007\/s12072-023-10577-y","volume":"17","author":"B Simbrunner","year":"2023","unstructured":"Simbrunner B, et al. Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome. Hepatol Int. 2023;17:1532\u201344. https:\/\/doi.org\/10.1007\/s12072-023-10577-y.","journal-title":"Hepatol Int"},{"key":"2997_CR206","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.3390\/life13061420","volume":"13","author":"E Dri","year":"2023","unstructured":"Dri E, et al. Inflammatory mediators of endothelial dysfunction. Life (Basel). 2023;13:1420. https:\/\/doi.org\/10.3390\/life13061420.","journal-title":"Life (Basel)"},{"key":"2997_CR207","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2741\/1270","volume":"9","author":"LL Horstman","year":"2004","unstructured":"Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci. 2004;9:1118\u201335. https:\/\/doi.org\/10.2741\/1270.","journal-title":"Front Biosci"},{"key":"2997_CR208","doi-asserted-by":"publisher","first-page":"166990","DOI":"10.1016\/j.bbadis.2023.166990","volume":"1870","author":"S Eissazadeh","year":"2024","unstructured":"Eissazadeh S, et al. Endoglin and soluble endoglin in liver sinusoidal endothelial dysfunction in vivo. Biochim Biophys Acta Mol Basis Dis. 2024;1870:166990. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166990.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2997_CR209","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/ar.23567","volume":"300","author":"KM Mak","year":"2017","unstructured":"Mak KM, Mei R. Basement membrane type IV collagen and laminin: an overview of their biology and value as fibrosis biomarkers of liver disease. Anat Rec (Hoboken). 2017;300:1371\u201390. https:\/\/doi.org\/10.1002\/ar.23567.","journal-title":"Anat Rec (Hoboken)"},{"key":"2997_CR210","doi-asserted-by":"publisher","first-page":"101721","DOI":"10.1016\/j.jcmgh.2025.101721","volume":"20","author":"Y Wang","year":"2026","unstructured":"Wang Y, et al. OGT-enriched hepatocyte-derived extracellular vesicles promote capillarization of liver sinusoidal endothelial cells in metabolic dysfunction-associated steatotic liver disease. Cell Mol Gastroenterol Hepatol. 2026;20:101721. https:\/\/doi.org\/10.1016\/j.jcmgh.2025.101721.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2997_CR211","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2362.2007.01814.x","volume":"37","author":"F Vizzutti","year":"2007","unstructured":"Vizzutti F, et al. ADMA correlates with portal pressure in patients with compensated cirrhosis. Eur J Clin Invest. 2007;37:509\u201315. https:\/\/doi.org\/10.1111\/j.1365-2362.2007.01814.x.","journal-title":"Eur J Clin Invest"},{"key":"2997_CR212","doi-asserted-by":"publisher","first-page":"167020","DOI":"10.1016\/j.bbadis.2024.167020","volume":"1870","author":"J Wang","year":"2024","unstructured":"Wang J, et al. Extracellular vesicles derived from liver sinusoidal endothelial cells inhibit the activation of hepatic stellate cells and Kupffer cells in vitro. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167020. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167020.","journal-title":"Biochim Biophys Acta Mol Basis Dis"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02997-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02997-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02997-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:34:59Z","timestamp":1781238899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02997-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":212,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2997"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02997-8","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"351"}}